PlainPharmaWatch

CMS Open Payments · Program Year 2024

Oregon

Oregon received $19,875,969.63 in pharmaceutical-industry payments to 6,484 physicians and 11 teaching hospitals across 77,416 transactions.

$19.9M
Total payments
$16.2M
To physicians
$1.9M
To teaching hospitals
#34
of 59 states

In CMS Open Payments Program Year 2024, pharmaceutical and medical-device companies reported $19.9M in payments to 6,484 physicians and 11 teaching hospitals in Oregon. That ranks Oregon #34 of 59 states and territories (0.1% of the US total), averaging $2.5K per physician. Figures are company-reported under the Physician Payments Sunshine Act; a reported payment is a financial relationship, not evidence of wrongdoing.

The verdict

Oregon pairs below-median payment volume with a physician-heavy payment mix.

#34
of 59 states
0.1%
of the national total
81.6%
to physicians vs. hospitals
6,484
physicians paid

What the Data Shows for Oregon

Oregon sits in the middle volume tercile at #34 of 59 (0.1% of US dollars), with $19,875,969.63 reaching 6,484 physicians and 11 teaching hospitals.

Physician versus hospital mix is near the corpus middle (81.6% / 9.3%). Average transaction $256.74. Leading nature of payment: "Compensation for Services Other Than Consulting" at $5.9M (29.5% of the state file; top-three natures 66.1%).

Oregon sits in the 44th percentile (lower-volume tier). Just above: Oklahoma ($24.3M). Just below: Iowa ($17.6M). For context: top-ranked California ($342.4M) is 17.2× larger than Oregon. CMS Sunshine Act framework and methodology.

Physician vs Hospital Payments

How pharmaceutical payments in Oregon are distributed between physicians and teaching hospitals.

Physician Payments

$16.2M

81.6% of total · 6,484 recipients · $2.5K avg

Teaching Hospital Payments

$1.9M

9.3% of total · 11 hospitals · $168.7K avg

Payment Breakdown by Type

Oregon has 15 types of pharmaceutical payments. "Compensation for Services Other Than Consulting" accounts for 29.5%.

Nature concentration in Oregon

Top three Open Payments natures are 66.1% of state dollars; residual is every other reported nature

Compensation for Services Ot…$5.9MConsulting Fee$4.2MRoyalty or License$3.0MAll other natures (12)$6.7M

Payment categories in Oregon

Top categories by total reported dollar volume

1. Compensation for Services…$5.9M2. Consulting Fee$4.2M3. Royalty or License$3.0M4. Food and Beverage$2.3M5. Travel and Lodging$1.9M6. Education$758.4K7. Grant$635.2K8. Honoraria$350.5K9. Long-Term Medical Supply …$256.1K10. Compensation for Faculty…$219.8K
Payment Type Amount Transactions
Compensation for Services Other Than Consulting $5.9M 2,232
Consulting Fee $4.2M 1,715
Royalty or License $3.0M 101
Food and Beverage $2.3M 64,228
Travel and Lodging $1.9M 6,234
Education $758.4K 1,871
Grant $635.2K 70
Honoraria $350.5K 122
Long-Term Medical Supply or Device Loan $256.1K 76
Compensation for Faculty or Speaker (Medical Education) $219.8K 130
Space Rental or Facility Fees $155.0K 74
Gift $66.8K 478
Debt Forgiveness $60.3K 24
Entertainment $8.3K 58
Charitable Contribution $598.14 3

Data Source: Centers for Medicare & Medicaid Services (CMS) Open Payments, Program Year 2024. Data includes general payments, research payments, and physician ownership/investment interests as required by the Physician Payments Sunshine Act. Total industry payments: $13.9B across 1,925 companies.

Source: CMS Open Payments Database Industry payments to physicians and teaching hospitals · 2024

What Oregon totals can and cannot tell you

The aggregate payment figure for Oregon measures reportable industry–physician engagement inside this state's geographic footprint for Program Year 2024, not any one physician's or hospital's relationship with industry. CMS collects the data under the Physician Payments Sunshine Act; manufacturers must report transfers of value above the de minimis threshold. The file does not capture DTC advertising, internal R&D, wholesale drug pricing, or salary support that is not a reportable transfer of value.

Correlations between payment receipt and prescribing appear in peer-reviewed work for specific drugs and specialties, but this page's state total does not establish causation. Open the company and recipient detail pages for category and year-over-year cuts.

View saved (states)
Download Oregon's data (CSV)
Embed this widget

Copy this snippet to embed a live-linked card on your own site.

Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.